Visual Function in Carriers of X-Linked Retinitis Pigmentosa

Purpose To determine the frequency and severity of visual function loss in female carriers of X-linked retinitis pigmentosa (XLRP). Design Case series. Participants Two hundred seventy-six XLRP carriers with cross-sectional data (n = 242) and longitudinal data (n = 34; median follow-up, 16 years; fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ophthalmology (Rochester, Minn.) Minn.), 2015-09, Vol.122 (9), p.1899-1906
Hauptverfasser: Comander, Jason, MD, PhD, Weigel-DiFranco, Carol, MA, Sandberg, Michael A., PhD, Berson, Eliot L., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1906
container_issue 9
container_start_page 1899
container_title Ophthalmology (Rochester, Minn.)
container_volume 122
creator Comander, Jason, MD, PhD
Weigel-DiFranco, Carol, MA
Sandberg, Michael A., PhD
Berson, Eliot L., MD
description Purpose To determine the frequency and severity of visual function loss in female carriers of X-linked retinitis pigmentosa (XLRP). Design Case series. Participants Two hundred seventy-six XLRP carriers with cross-sectional data (n = 242) and longitudinal data (n = 34; median follow-up, 16 years; follow-up range, 3–37 years). Half of the carriers were from RPGR - or RP2 -genotyped families. Methods Retrospective medical records review. Main Outcome Measures Visual acuities, visual field areas, final dark adaptation thresholds, and full-field electroretinography (ERG) responses to 0.5-Hz and 30-Hz flashes. Results In genotyped families, 40% of carriers showed a baseline abnormality on at least 1 of 3 psychophysical tests. There was a wide range of function among carriers. For example, 3 of 121 (2%) genotyped carriers were legally blind because of poor visual acuity, some as young as 35 years. Visual fields were less affected than visual acuity. In all carriers, the average ERG amplitude to 30-Hz flashes was approximately 50% of normal, and the average exponential rate of amplitude loss over time was half that of XLRP males (3.7%/year vs. 7.4%/year, respectively). Among obligate carriers with affected fathers, sons, or both, 53 of 55 (96%) had abnormal baseline ERG results. Some carriers who initially had completely normal fundi in both eyes went on to experience moderately decreased vision, although not legal blindness. Among carriers with RPGR mutations, those with mutations in ORF15, compared with those in exons 1–14, had worse final dark adaptation thresholds and lower 0.5-Hz and 30-Hz ERG amplitudes. Conclusions Most carriers of XLRP had mildly or moderately reduced visual function but rarely became legally blind. In most cases, obligate carriers could be identified by ERG testing. Carriers of RPGR ORF15 mutations tended to have worse visual function than carriers of RPGR exon 1 through 14 mutations. Because XLRP carrier ERG amplitudes and decay rates over time were on average half of those of affected men, these observations were consistent with the Lyon hypothesis of random X-inactivation.
doi_str_mv 10.1016/j.ophtha.2015.05.039
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4562908</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0161642015005382</els_id><sourcerecordid>1706577958</sourcerecordid><originalsourceid>FETCH-LOGICAL-c654t-ad9afcdb9c6c2d5a9b9cd564bebbb0c7e18ee7085aded9065397213e40fc442f3</originalsourceid><addsrcrecordid>eNqFkVuLFDEQhYMo7rj6D0T60ZceK9eegAgyuCoMKN7wLaST6p3M9iRj0r2w_94Ms66XF6EggVSdU_kOIU8pLClQ9WK3TIfttLVLBlQuoRbX98iCSqFb0VF-nyxqG22VYHBGHpWyAwCluHhIzpiigkvBFuTlt1BmOzYXc3RTSLEJsVnbnAPm0qSh-d5uQrxC33zCKcQwhdJ8DJd7jFMq9jF5MNix4JPb85x8vXjzZf2u3Xx4-379etM6JcXUWq_t4HyvnXLMS6vrzUsleuz7HlyHdIXYwUpaj16Dklx3jHIUMDgh2MDPyauT7mHu9-hddc92NIcc9jbfmGSD-fslhq25TNdGSMU0rKrA81uBnH7MWCazD8XhONqIaS6GdtW167Q8topTq8uplIzDnQ0FcwRvduYE3hzBG6jFdR179ueKd0O_SP_-A1ZQ1xWvKS5gdOhDRjcZn8L_HP4VcGNNxNnxCm-w7NKcYw3BUFOYAfP5GP4xeyoBJF8x_hM5d6yz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706577958</pqid></control><display><type>article</type><title>Visual Function in Carriers of X-Linked Retinitis Pigmentosa</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Comander, Jason, MD, PhD ; Weigel-DiFranco, Carol, MA ; Sandberg, Michael A., PhD ; Berson, Eliot L., MD</creator><creatorcontrib>Comander, Jason, MD, PhD ; Weigel-DiFranco, Carol, MA ; Sandberg, Michael A., PhD ; Berson, Eliot L., MD</creatorcontrib><description>Purpose To determine the frequency and severity of visual function loss in female carriers of X-linked retinitis pigmentosa (XLRP). Design Case series. Participants Two hundred seventy-six XLRP carriers with cross-sectional data (n = 242) and longitudinal data (n = 34; median follow-up, 16 years; follow-up range, 3–37 years). Half of the carriers were from RPGR - or RP2 -genotyped families. Methods Retrospective medical records review. Main Outcome Measures Visual acuities, visual field areas, final dark adaptation thresholds, and full-field electroretinography (ERG) responses to 0.5-Hz and 30-Hz flashes. Results In genotyped families, 40% of carriers showed a baseline abnormality on at least 1 of 3 psychophysical tests. There was a wide range of function among carriers. For example, 3 of 121 (2%) genotyped carriers were legally blind because of poor visual acuity, some as young as 35 years. Visual fields were less affected than visual acuity. In all carriers, the average ERG amplitude to 30-Hz flashes was approximately 50% of normal, and the average exponential rate of amplitude loss over time was half that of XLRP males (3.7%/year vs. 7.4%/year, respectively). Among obligate carriers with affected fathers, sons, or both, 53 of 55 (96%) had abnormal baseline ERG results. Some carriers who initially had completely normal fundi in both eyes went on to experience moderately decreased vision, although not legal blindness. Among carriers with RPGR mutations, those with mutations in ORF15, compared with those in exons 1–14, had worse final dark adaptation thresholds and lower 0.5-Hz and 30-Hz ERG amplitudes. Conclusions Most carriers of XLRP had mildly or moderately reduced visual function but rarely became legally blind. In most cases, obligate carriers could be identified by ERG testing. Carriers of RPGR ORF15 mutations tended to have worse visual function than carriers of RPGR exon 1 through 14 mutations. Because XLRP carrier ERG amplitudes and decay rates over time were on average half of those of affected men, these observations were consistent with the Lyon hypothesis of random X-inactivation.</description><identifier>ISSN: 0161-6420</identifier><identifier>EISSN: 1549-4713</identifier><identifier>DOI: 10.1016/j.ophtha.2015.05.039</identifier><identifier>PMID: 26143542</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Dark Adaptation ; Electroretinography ; Eye Proteins - genetics ; Female ; Genetic Association Studies ; Genetic Diseases, X-Linked - physiopathology ; Genotyping Techniques ; Heterozygote ; Humans ; Infant ; Intracellular Signaling Peptides and Proteins - genetics ; Membrane Proteins - genetics ; Middle Aged ; Ophthalmology ; Photic Stimulation ; Retina - physiopathology ; Retinitis Pigmentosa - genetics ; Retinitis Pigmentosa - physiopathology ; Retrospective Studies ; Vision Disorders - physiopathology ; Visual Acuity - physiology ; Visual Fields - physiology</subject><ispartof>Ophthalmology (Rochester, Minn.), 2015-09, Vol.122 (9), p.1899-1906</ispartof><rights>American Academy of Ophthalmology</rights><rights>2015 American Academy of Ophthalmology</rights><rights>Copyright © 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c654t-ad9afcdb9c6c2d5a9b9cd564bebbb0c7e18ee7085aded9065397213e40fc442f3</citedby><cites>FETCH-LOGICAL-c654t-ad9afcdb9c6c2d5a9b9cd564bebbb0c7e18ee7085aded9065397213e40fc442f3</cites><orcidid>0000-0002-4257-7145</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ophtha.2015.05.039$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,777,781,882,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26143542$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Comander, Jason, MD, PhD</creatorcontrib><creatorcontrib>Weigel-DiFranco, Carol, MA</creatorcontrib><creatorcontrib>Sandberg, Michael A., PhD</creatorcontrib><creatorcontrib>Berson, Eliot L., MD</creatorcontrib><title>Visual Function in Carriers of X-Linked Retinitis Pigmentosa</title><title>Ophthalmology (Rochester, Minn.)</title><addtitle>Ophthalmology</addtitle><description>Purpose To determine the frequency and severity of visual function loss in female carriers of X-linked retinitis pigmentosa (XLRP). Design Case series. Participants Two hundred seventy-six XLRP carriers with cross-sectional data (n = 242) and longitudinal data (n = 34; median follow-up, 16 years; follow-up range, 3–37 years). Half of the carriers were from RPGR - or RP2 -genotyped families. Methods Retrospective medical records review. Main Outcome Measures Visual acuities, visual field areas, final dark adaptation thresholds, and full-field electroretinography (ERG) responses to 0.5-Hz and 30-Hz flashes. Results In genotyped families, 40% of carriers showed a baseline abnormality on at least 1 of 3 psychophysical tests. There was a wide range of function among carriers. For example, 3 of 121 (2%) genotyped carriers were legally blind because of poor visual acuity, some as young as 35 years. Visual fields were less affected than visual acuity. In all carriers, the average ERG amplitude to 30-Hz flashes was approximately 50% of normal, and the average exponential rate of amplitude loss over time was half that of XLRP males (3.7%/year vs. 7.4%/year, respectively). Among obligate carriers with affected fathers, sons, or both, 53 of 55 (96%) had abnormal baseline ERG results. Some carriers who initially had completely normal fundi in both eyes went on to experience moderately decreased vision, although not legal blindness. Among carriers with RPGR mutations, those with mutations in ORF15, compared with those in exons 1–14, had worse final dark adaptation thresholds and lower 0.5-Hz and 30-Hz ERG amplitudes. Conclusions Most carriers of XLRP had mildly or moderately reduced visual function but rarely became legally blind. In most cases, obligate carriers could be identified by ERG testing. Carriers of RPGR ORF15 mutations tended to have worse visual function than carriers of RPGR exon 1 through 14 mutations. Because XLRP carrier ERG amplitudes and decay rates over time were on average half of those of affected men, these observations were consistent with the Lyon hypothesis of random X-inactivation.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Dark Adaptation</subject><subject>Electroretinography</subject><subject>Eye Proteins - genetics</subject><subject>Female</subject><subject>Genetic Association Studies</subject><subject>Genetic Diseases, X-Linked - physiopathology</subject><subject>Genotyping Techniques</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Infant</subject><subject>Intracellular Signaling Peptides and Proteins - genetics</subject><subject>Membrane Proteins - genetics</subject><subject>Middle Aged</subject><subject>Ophthalmology</subject><subject>Photic Stimulation</subject><subject>Retina - physiopathology</subject><subject>Retinitis Pigmentosa - genetics</subject><subject>Retinitis Pigmentosa - physiopathology</subject><subject>Retrospective Studies</subject><subject>Vision Disorders - physiopathology</subject><subject>Visual Acuity - physiology</subject><subject>Visual Fields - physiology</subject><issn>0161-6420</issn><issn>1549-4713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkVuLFDEQhYMo7rj6D0T60ZceK9eegAgyuCoMKN7wLaST6p3M9iRj0r2w_94Ms66XF6EggVSdU_kOIU8pLClQ9WK3TIfttLVLBlQuoRbX98iCSqFb0VF-nyxqG22VYHBGHpWyAwCluHhIzpiigkvBFuTlt1BmOzYXc3RTSLEJsVnbnAPm0qSh-d5uQrxC33zCKcQwhdJ8DJd7jFMq9jF5MNix4JPb85x8vXjzZf2u3Xx4-379etM6JcXUWq_t4HyvnXLMS6vrzUsleuz7HlyHdIXYwUpaj16Dklx3jHIUMDgh2MDPyauT7mHu9-hddc92NIcc9jbfmGSD-fslhq25TNdGSMU0rKrA81uBnH7MWCazD8XhONqIaS6GdtW167Q8topTq8uplIzDnQ0FcwRvduYE3hzBG6jFdR179ueKd0O_SP_-A1ZQ1xWvKS5gdOhDRjcZn8L_HP4VcGNNxNnxCm-w7NKcYw3BUFOYAfP5GP4xeyoBJF8x_hM5d6yz</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Comander, Jason, MD, PhD</creator><creator>Weigel-DiFranco, Carol, MA</creator><creator>Sandberg, Michael A., PhD</creator><creator>Berson, Eliot L., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4257-7145</orcidid></search><sort><creationdate>20150901</creationdate><title>Visual Function in Carriers of X-Linked Retinitis Pigmentosa</title><author>Comander, Jason, MD, PhD ; Weigel-DiFranco, Carol, MA ; Sandberg, Michael A., PhD ; Berson, Eliot L., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c654t-ad9afcdb9c6c2d5a9b9cd564bebbb0c7e18ee7085aded9065397213e40fc442f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Dark Adaptation</topic><topic>Electroretinography</topic><topic>Eye Proteins - genetics</topic><topic>Female</topic><topic>Genetic Association Studies</topic><topic>Genetic Diseases, X-Linked - physiopathology</topic><topic>Genotyping Techniques</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Infant</topic><topic>Intracellular Signaling Peptides and Proteins - genetics</topic><topic>Membrane Proteins - genetics</topic><topic>Middle Aged</topic><topic>Ophthalmology</topic><topic>Photic Stimulation</topic><topic>Retina - physiopathology</topic><topic>Retinitis Pigmentosa - genetics</topic><topic>Retinitis Pigmentosa - physiopathology</topic><topic>Retrospective Studies</topic><topic>Vision Disorders - physiopathology</topic><topic>Visual Acuity - physiology</topic><topic>Visual Fields - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Comander, Jason, MD, PhD</creatorcontrib><creatorcontrib>Weigel-DiFranco, Carol, MA</creatorcontrib><creatorcontrib>Sandberg, Michael A., PhD</creatorcontrib><creatorcontrib>Berson, Eliot L., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Ophthalmology (Rochester, Minn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Comander, Jason, MD, PhD</au><au>Weigel-DiFranco, Carol, MA</au><au>Sandberg, Michael A., PhD</au><au>Berson, Eliot L., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Visual Function in Carriers of X-Linked Retinitis Pigmentosa</atitle><jtitle>Ophthalmology (Rochester, Minn.)</jtitle><addtitle>Ophthalmology</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>122</volume><issue>9</issue><spage>1899</spage><epage>1906</epage><pages>1899-1906</pages><issn>0161-6420</issn><eissn>1549-4713</eissn><abstract>Purpose To determine the frequency and severity of visual function loss in female carriers of X-linked retinitis pigmentosa (XLRP). Design Case series. Participants Two hundred seventy-six XLRP carriers with cross-sectional data (n = 242) and longitudinal data (n = 34; median follow-up, 16 years; follow-up range, 3–37 years). Half of the carriers were from RPGR - or RP2 -genotyped families. Methods Retrospective medical records review. Main Outcome Measures Visual acuities, visual field areas, final dark adaptation thresholds, and full-field electroretinography (ERG) responses to 0.5-Hz and 30-Hz flashes. Results In genotyped families, 40% of carriers showed a baseline abnormality on at least 1 of 3 psychophysical tests. There was a wide range of function among carriers. For example, 3 of 121 (2%) genotyped carriers were legally blind because of poor visual acuity, some as young as 35 years. Visual fields were less affected than visual acuity. In all carriers, the average ERG amplitude to 30-Hz flashes was approximately 50% of normal, and the average exponential rate of amplitude loss over time was half that of XLRP males (3.7%/year vs. 7.4%/year, respectively). Among obligate carriers with affected fathers, sons, or both, 53 of 55 (96%) had abnormal baseline ERG results. Some carriers who initially had completely normal fundi in both eyes went on to experience moderately decreased vision, although not legal blindness. Among carriers with RPGR mutations, those with mutations in ORF15, compared with those in exons 1–14, had worse final dark adaptation thresholds and lower 0.5-Hz and 30-Hz ERG amplitudes. Conclusions Most carriers of XLRP had mildly or moderately reduced visual function but rarely became legally blind. In most cases, obligate carriers could be identified by ERG testing. Carriers of RPGR ORF15 mutations tended to have worse visual function than carriers of RPGR exon 1 through 14 mutations. Because XLRP carrier ERG amplitudes and decay rates over time were on average half of those of affected men, these observations were consistent with the Lyon hypothesis of random X-inactivation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26143542</pmid><doi>10.1016/j.ophtha.2015.05.039</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-4257-7145</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0161-6420
ispartof Ophthalmology (Rochester, Minn.), 2015-09, Vol.122 (9), p.1899-1906
issn 0161-6420
1549-4713
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4562908
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Dark Adaptation
Electroretinography
Eye Proteins - genetics
Female
Genetic Association Studies
Genetic Diseases, X-Linked - physiopathology
Genotyping Techniques
Heterozygote
Humans
Infant
Intracellular Signaling Peptides and Proteins - genetics
Membrane Proteins - genetics
Middle Aged
Ophthalmology
Photic Stimulation
Retina - physiopathology
Retinitis Pigmentosa - genetics
Retinitis Pigmentosa - physiopathology
Retrospective Studies
Vision Disorders - physiopathology
Visual Acuity - physiology
Visual Fields - physiology
title Visual Function in Carriers of X-Linked Retinitis Pigmentosa
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T03%3A56%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Visual%20Function%20in%20Carriers%20of%20X-Linked%20Retinitis%20Pigmentosa&rft.jtitle=Ophthalmology%20(Rochester,%20Minn.)&rft.au=Comander,%20Jason,%20MD,%20PhD&rft.date=2015-09-01&rft.volume=122&rft.issue=9&rft.spage=1899&rft.epage=1906&rft.pages=1899-1906&rft.issn=0161-6420&rft.eissn=1549-4713&rft_id=info:doi/10.1016/j.ophtha.2015.05.039&rft_dat=%3Cproquest_pubme%3E1706577958%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1706577958&rft_id=info:pmid/26143542&rft_els_id=1_s2_0_S0161642015005382&rfr_iscdi=true